시장조사 보고서 : 세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년

■ 영문 제목 : Global SARS-Cov-2 Vaccine (Vero Cell) Market Growth 2021-2026
	■ 상품코드 : LPI-2201K02170 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 98 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 SARS-Cov-2 백신 (베로셀)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (바이러스 불활성화 백신, 분할 백신, 서브 유닛 백신, 기타)와 용도별 시장규모 (특수용, 일반용) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 SARS-Cov-2 백신 (베로셀) 시장 점유율
- 지역별 SARS-Cov-2 백신 (베로셀) 시장규모
- 주요지역의 종류별 시장규모 (바이러스 불활성화 백신, 분할 백신, 서브 유닛 백신, 기타)
- 주요지역의 용도별 시장규모 (특수용, 일반용)
- 미주의 SARS-Cov-2 백신 (베로셀) 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 SARS-Cov-2 백신 (베로셀) 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 SARS-Cov-2 백신 (베로셀) 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 SARS-Cov-2 백신 (베로셀) 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 SARS-Cov-2 백신 (베로셀) 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Sinopharm, Sinovac Biotech, BIBP, IMBCAMS,China, WIBP
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of SARS-Cov-2 Vaccine (Vero Cell) will have significant change from previous year. By the most conservative estimates of global SARS-Cov-2 Vaccine (Vero Cell) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the SARS-Cov-2 Vaccine (Vero Cell) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of SARS-Cov-2 Vaccine (Vero Cell) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Whole Virus Inactivated Vaccine
Split Vaccine
Subunit Vaccine
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Special Population
General Population

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Sinopharm
Sinovac Biotech
BIBP
IMBCAMS,China
WIBP

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Consumption 2016-2026
2.1.2 SARS-Cov-2 Vaccine (Vero Cell) Consumption CAGR by Region
2.2 SARS-Cov-2 Vaccine (Vero Cell) Segment by Type
2.2.1 Whole Virus Inactivated Vaccine
2.2.2 Split Vaccine
2.2.3 Subunit Vaccine
2.2.4 Others
2.3 SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
2.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021)
2.3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue and Market Share by Type (2016-2021)
2.3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Type (2016-2021)
2.4 SARS-Cov-2 Vaccine (Vero Cell) Segment by Application
2.4.1 Special Population
2.4.2 General Population
2.5 SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
2.5.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Market Share by Application (2016-2021)
2.5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue and Market Share by Application (2016-2021)
2.5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Application (2016-2021)

3 Global SARS-Cov-2 Vaccine (Vero Cell) by Company
3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company
3.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Company (2019-2021)
3.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company (2019-2021)
3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company
3.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Company (2019-2021)
3.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company (2019-2021)
3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Company
3.4 Global Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Product Location Distribution
3.4.2 Players SARS-Cov-2 Vaccine (Vero Cell) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 SARS-Cov-2 Vaccine (Vero Cell) by Region
4.1 Global SARS-Cov-2 Vaccine (Vero Cell) by Region
4.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
4.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region
4.2 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.3 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.4 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.5 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Growth

5 Americas
5.1 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
5.1.1 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021)
5.1.2 Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021)
5.2 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
5.3 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
6.1.1 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2016-2021)
6.1.2 APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2016-2021)
6.2 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
6.3 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe SARS-Cov-2 Vaccine (Vero Cell) by Country
7.1.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021)
7.1.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021)
7.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
7.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) by Country
8.1.1 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021)
8.1.2 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021)
8.2 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
8.3 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors
10.3 SARS-Cov-2 Vaccine (Vero Cell) Customer

11 Global SARS-Cov-2 Vaccine (Vero Cell) Market Forecast
11.1 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Region
11.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Regions (2021-2026)
11.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Type
11.7 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Application

12 Key Players Analysis
12.1 Sinopharm
12.1.1 Sinopharm Company Information
12.1.2 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Offered
12.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sinopharm Main Business Overview
12.1.5 Sinopharm Latest Developments
12.2 Sinovac Biotech
12.2.1 Sinovac Biotech Company Information
12.2.2 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Offered
12.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sinovac Biotech Main Business Overview
12.2.5 Sinovac Biotech Latest Developments
12.3 BIBP
12.3.1 BIBP Company Information
12.3.2 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Offered
12.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 BIBP Main Business Overview
12.3.5 BIBP Latest Developments
12.4 IMBCAMS,China
12.4.1 IMBCAMS,China Company Information
12.4.2 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Offered
12.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 IMBCAMS,China Main Business Overview
12.4.5 IMBCAMS,China Latest Developments
12.5 WIBP
12.5.1 WIBP Company Information
12.5.2 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Offered
12.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 WIBP Main Business Overview
12.5.5 WIBP Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. SARS-Cov-2 Vaccine (Vero Cell) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Whole Virus Inactivated Vaccine
Table 3. Major Players of Split Vaccine
Table 4. Major Players of Subunit Vaccine
Table 5. Major Players of Others
Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2016-2021) & (K Units)
Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021)
Table 8. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2016-2021) & ($ million)
Table 9. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2016-2021)
Table 10. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Type (2016-2021)
Table 11. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2016-2021) & (K Units)
Table 12. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021)
Table 13. Global SARS-Cov-2 Vaccine (Vero Cell) Value by Application (2016-2021)
Table 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2016-2021)
Table 15. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Application (2016-2021)
Table 16. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Company (2019-2021) & (K Units)
Table 17. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company (2019-2021)
Table 18. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Company (2019-2021) ($ Millions)
Table 19. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company (2019-2021)
Table 20. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Company (2019-2021)
Table 21. Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Producing Area Distribution and Sales Area
Table 22. Players SARS-Cov-2 Vaccine (Vero Cell) Products Offered
Table 23. SARS-Cov-2 Vaccine (Vero Cell) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2016-2021) (K Units)
Table 27. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2016-2021)
Table 28. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2016-2021)
Table 30. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021) & (K Units)
Table 31. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2016-2021)
Table 32. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2016-2021)
Table 34. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2016-2021) & (K Units)
Table 35. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021)
Table 36. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2016-2021) & (K Units)
Table 37. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021)
Table 38. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2016-2021) & (K Units)
Table 39. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2016-2021)
Table 40. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2016-2021)
Table 42. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2016-2021) & (K Units)
Table 43. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021)
Table 44. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2016-2021) & (K Units)
Table 45. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021)
Table 46. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021) & (K Units)
Table 47. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2016-2021)
Table 48. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2016-2021)
Table 50. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2016-2021) & (K Units)
Table 51. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021)
Table 52. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2016-2021) & (K Units)
Table 53. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of SARS-Cov-2 Vaccine (Vero Cell)
Table 63. Key Application and Potential Industries of SARS-Cov-2 Vaccine (Vero Cell)
Table 64. Key Challenges of SARS-Cov-2 Vaccine (Vero Cell)
Table 65. Key Trends of SARS-Cov-2 Vaccine (Vero Cell)
Table 66. SARS-Cov-2 Vaccine (Vero Cell) Distributors List
Table 67. SARS-Cov-2 Vaccine (Vero Cell) Customer List
Table 68. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global SARS-Cov-2 Vaccine (Vero Cell) Consumption Market Forecast by Region
Table 70. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Type (2021-2026)
Table 82. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Application (2021-2026)
Table 86. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Application (2021-2026)
Table 88. Sinopharm Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 89. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Offered
Table 90. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. Sinopharm Main Business
Table 92. Sinopharm Latest Developments
Table 93. Sinovac Biotech Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 94. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Offered
Table 95. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Sinovac Biotech Main Business
Table 97. Sinovac Biotech Latest Developments
Table 98. BIBP Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 99. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Offered
Table 100. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. BIBP Main Business
Table 102. BIBP Latest Developments
Table 103. IMBCAMS,China Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 104. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Offered
Table 105. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. IMBCAMS,China Main Business
Table 107. IMBCAMS,China Latest Developments
Table 108. WIBP Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 109. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Offered
Table 110. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. WIBP Main Business
Table 112. WIBP Latest Developments
List of Figures
Figure 1. Picture of SARS-Cov-2 Vaccine (Vero Cell)
Figure 2. SARS-Cov-2 Vaccine (Vero Cell) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Whole Virus Inactivated Vaccine
Figure 10. Product Picture of Split Vaccine
Figure 11. Product Picture of Subunit Vaccine
Figure 12. Product Picture of Others
Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type in 2020
Figure 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2016-2021)
Figure 15. SARS-Cov-2 Vaccine (Vero Cell) Consumed in Special Population
Figure 16. Global SARS-Cov-2 Vaccine (Vero Cell) Market: Special Population (2016-2021) & (K Units)
Figure 17. SARS-Cov-2 Vaccine (Vero Cell) Consumed in General Population
Figure 18. Global SARS-Cov-2 Vaccine (Vero Cell) Market: General Population (2016-2021) & (K Units)
Figure 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021)
Figure 20. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application in 2020
Figure 21. SARS-Cov-2 Vaccine (Vero Cell) Revenue Market by Company in 2020 ($ Million)
Figure 22. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company in 2020
Figure 23. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Regions (2016-2021)
Figure 24. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region in 2020
Figure 25. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales 2016-2021 (K Units)
Figure 26. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue 2016-2021 ($ Millions)
Figure 27. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales 2016-2021 (K Units)
Figure 28. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue 2016-2021 ($ Millions)
Figure 29. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales 2016-2021 (K Units)
Figure 30. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue 2016-2021 ($ Millions)
Figure 33. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2020
Figure 34. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2020
Figure 35. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type in 2020
Figure 36. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application in 2020
Figure 37. United States SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region in 2020
Figure 42. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Regions in 2020
Figure 43. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type in 2020
Figure 44. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application in 2020
Figure 45. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 49. India SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2020
Figure 52. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2020
Figure 53. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type in 2020
Figure 54. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application in 2020
Figure 55. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 56. France SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2020
Figure 61. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type in 2020
Figure 63. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application in 2020
Figure 64. Egypt SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

※본 조사보고서 [세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년] (코드 : LPI-2201K02170) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 종양 세포 백신 시장예측 2021년-2026년
LPI-2201K02666 / LP Information / 2021년 12월 / 본 조사보고서는 종양 세포 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Tumour-cell Vaccine will have significant change from previous year. By the most conservative estimates of global Tumour-cell Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 비강 스프레이 인플루엔자 백신 시장예측 2021년-2026년
LPI-2201K02102 / LP Information / 2021년 12월 / 본 조사보고서는 비강 스프레이 인플루엔자 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Nasal Spray Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Nasal Spray Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 폐렴구균 백신 시장예측 2021년-2026년
LPI-2201K02154 / LP Information / 2021년 12월 / 본 조사보고서는 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pneumococcal Bacteria Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Bacteria Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 수두 백신 시장예측 2021년-2026년
LPI-2201K02212 / LP Information / 2021년 12월 / 본 조사보고서는 수두 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Varicella Vaccine will have significant change from previous year. By the most conservative estimates of global Varicella Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3787.8 million in 2020. Over...

세계의 수막구균 백신 시장예측 2021년-2026년
LPI-2201K02087 / LP Information / 2021년 12월 / 본 조사보고서는 수막구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Meningococcal Vaccine will have significant change from previous year. By the most conservative estimates of global Meningococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 245.5 million in 2020. Over...

세계의 백신 투여 시장예측 2021년-2026년
LPI-2201K02327 / LP Information / 2021년 12월 / 본 조사보고서는 백신 투여의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Vaccine Administration will have significant change from previous year. By the most conservative estimates of global Vaccine Administration market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...